{"database": "lobbying", "table": "lobbying_activities", "rows": [[1149760, "2432ced9-d54e-4fa4-bc33-c080648f1dbb", "Q3", "VENABLE LLP", 39941, "ENDO PHARMACEUTICALS INC", 2011, "third_quarter", "PHA", "General issues affecting the pharmaceutical industry\nThe Life Sciences Investment Act", "HOUSE OF REPRESENTATIVES,SENATE", 40000, null, 0, 0, "2011-10-14T17:32:41.580000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["1149760"], "units": {}, "query_ms": 0.35945198033005, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}